- Conditions
- Aortic Stenosis
- Interventions
- Not listed
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Sacramento, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–19
of 19
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Calcific Aortic Stenosis, Calcific Aortic Stenosis - Bicuspid Valve, Aortic Valve Disease, Aortic Valve Calcification, Aortic Diseases, Aortic Aneurysm, Aortic Valve Cusp Abnormality, Aortic Valve Disease Mixed, Aortic Valve Insufficiency
- Interventions
- Patients scheduled to undergo aortic valve replacement or aortic surgery at BIDMC will be approached for participation in this study.
- Procedure
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 20 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Breast Cancer, Colon Cancer, Lung Cancer, Skin Cancer, Rectum Cancer
- Interventions
- Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C), Active control comparator
- Behavioral
- Lead sponsor
- University of Arizona
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 3
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Ann Arbor, Michigan
- Conditions
- Mantle Cell Lymphoma (MCL)
- Interventions
- Acalabrutinib, Venetoclax, Rituximab
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 5
- States / cities
- Hackensack, New Jersey • Stony Brook, New York • Cleveland, Ohio + 2 more
- Conditions
- Heart Valve Disease
- Interventions
- On-X valve using reduced anticoagulation, On-X Valve with Standard warfarin Therapy
- Device
- Lead sponsor
- On-X Life Technologies, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 977 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2023
- U.S. locations
- 44
- States / cities
- Tucson, Arizona • Loma Linda, California • Hartford, Connecticut + 34 more
- Conditions
- Right Ventricular Dysfunction
- Interventions
- 3D TEE RVEF
- Diagnostic Test
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Type 1 Gaucher Disease
- Interventions
- Safety and efficacy assessments
- Other
- Lead sponsor
- AVROBIO
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 2
- States / cities
- Iowa City, Iowa • Hackensack, New Jersey
- Conditions
- Coronary Artery Bypass Graft Surgery, Aortic Valve Replacement
- Interventions
- Albumin Solution, Lactated Ringer's Solution
- Other
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 131 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Breast Cancer
- Interventions
- Pre-Visit Patient Text Message, Post-Visit Patient Text Messages, Smart Data Element (SDE)
- Behavioral
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Other
- Eligibility
- 40 Years to 74 Years · Female only
- Enrollment
- 8,490 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Lancaster, Pennsylvania
- Conditions
- Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery
- Interventions
- Sugammadex, Placebo
- Drug · Other
- Lead sponsor
- Yale University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Gaucher Disease
- Interventions
- AVR-RD-02
- Biological
- Lead sponsor
- John Bernat
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2037
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Heart Failure
- Interventions
- Observational
- Other
- Lead sponsor
- LeukoLifeDx Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Timeline
- 2022 – 2023
- U.S. locations
- 3
- States / cities
- New Haven, Connecticut • Orlando, Florida • Kansas City, Missouri
- Conditions
- Aortic Valve Disease
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 273,365 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Gaucher Disease
- Interventions
- AVR-RD-02
- Drug
- Lead sponsor
- AVROBIO
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 4
- States / cities
- San Diego, California • Iowa City, Iowa • Hackensack, New Jersey + 1 more
- Conditions
- Aortic Stenosis
- Interventions
- Tadalafil, Placebo
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Carcinoma
- Interventions
- Nurse, AVR
- Behavioral
- Lead sponsor
- Michigan State University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 526 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 1
- States / cities
- East Lansing, Michigan
- Conditions
- Circadian Rhythm Disorders
- Interventions
- Blue light-blocking goggles, Clear goggles
- Other
- Lead sponsor
- West Virginia University
- Other
- Eligibility
- 45 Years to 75 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Morgantown, West Virginia
- Conditions
- Fabry Disease
- Interventions
- AVR-RD-01
- Drug
- Lead sponsor
- AVROBIO
- Industry
- Eligibility
- 16 Years to 50 Years · Male only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 2
- States / cities
- Hackensack, New Jersey • Pittsburgh, Pennsylvania
- Conditions
- Valve Heart Disease
- Interventions
- MRI, Transthoracic echocardiography exam
- Other
- Lead sponsor
- CryoLife, Inc.
- Industry
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Chicago, Illinois